nVerses Capital »

4d Molecular Therapeutics In shares owned by nVerses Capital

Quarter-by-quarter ownership of 4d Molecular Therapeutics In (FDMT) shares owned by nVerses Capital from 13F filings

Historical chart of nVerses Capital investment in 4d Molecular Therapeutics In

Tip: Access up to 7 years of quarterly data

All positions including 4d Molecular Therapeutics In held by nVerses Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in 4d Molecular Therapeutics In by nVerses Capital

Quarter filed Position value Share count Share price at filing
2024-09-30 $40k 3.7k 10.81

More positions owned by nVerses Capital

Edison International (EIX)
Brown & Brown (BRO)
Tyson Foods Cl A (TSN)
ResMed (RMD)
Motorola Solutions Com New (MSI)
American Intl Group Com New (AIG)
Masco Corporation (MAS)
Micron Technology (MU)
Republic Services (RSG)
PPL Corporation (PPL)
Norfolk Southern (NSC)
Marsh & McLennan Companies (MMC)
Fox Corp Cl A Com (FOXA)
Chipotle Mexican Grill (CMG)
Archer Daniels Midland Company (ADM)

View all positions for nVerses Capital

Top funds holding 4d Molecular Therapeutics In

BVF
RA Capital Management
BlackRock
VR Adviser
Deep Track Capital
Goldman Sachs Group
Henderson Group
Vanguard Group
State Street Corporation
Novo A/S
Redmile Group
Braidwell
Casdin Capital
Geode Capital Management
Polar Capital Holdings

View all funds holding 4d Molecular Therapeutics In